Filamon Limited
The startup develops a pharmaceutical drug that inhibits the progression of prostate cancer from a slow-growing state to an aggressive, life-threatening condition. By focusing on metastatic disease, the company aims to enhance the quality of life and extend survival for prostate cancer patients.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a pharmaceutical drug that inhibits the progression of prostate cancer from a slow-growing state to an aggressive, life-threatening condition. By focusing on metastatic disease, the company aims to enhance the quality of life and extend survival for prostate cancer patients.